Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives

Show simple item record

dc.contributor.author Leung, Yee Fun en
dc.contributor.author Pilkington, Lisa en
dc.contributor.author van Rensburg, M en
dc.contributor.author Jeon, CY en
dc.contributor.author Song, M en
dc.contributor.author Arabshahi, HJ en
dc.contributor.author De Zoysa, Gayan en
dc.contributor.author Sarojini Amma, Vijayalekshmi en
dc.contributor.author Denny, William en
dc.contributor.author Reynisson, Johannes en
dc.contributor.author Barker, David en
dc.date.accessioned 2017-04-20T02:33:21Z en
dc.date.issued 2016 en
dc.identifier.citation Bioorganic and Medicinal Chemistry 24(5):1142-1154 Mar 2016 en
dc.identifier.issn 0968-0896 en
dc.identifier.uri http://hdl.handle.net/2292/32606 en
dc.description.abstract Seventy nine derivatives of thieno[2,3-b]quinolines, tetrahydrothieno[2,3-b]quinoline, dihydrocyclopenta[b]thieno[3,2-e]pyridine, cyclohepta[b]thieno[3,2-e]pyridine and hexahydrocycloocta[b]thieno[3,2-e]pyridine were either synthesized or obtained commercially and tested for their antiproliferative activity against HCT116, MDA-MB-468 and MDA-MB-231 human cancer cell lines. The most potent eight compounds were active against all cell lines with IC50 values in the 80-250nM range. In general hexahydrocycloocta[b]thieno[3,2-e]pyridines were most active with increasing activity observed as larger cycloalkyl rings were fused to the pyridine ring. en
dc.relation.ispartofseries Bioorganic and Medicinal Chemistry en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives en
dc.type Journal Article en
dc.identifier.doi 10.1016/j.bmc.2016.01.047 en
pubs.issue 5 en
pubs.begin-page 1142 en
pubs.volume 24 en
dc.rights.holder Copyright: Elsevier en
dc.identifier.pmid 26853836 en
pubs.end-page 1154 en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Article en
pubs.elements-id 523073 en
pubs.org-id Medical and Health Sciences en
pubs.org-id Medical Sciences en
pubs.org-id Auckland Cancer Research en
pubs.org-id Science en
pubs.org-id Chemistry en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
dc.identifier.eissn 1464-3391 en
pubs.record-created-at-source-date 2017-07-01 en
pubs.online-publication-date 2016-01-27 en
pubs.dimensions-id 26853836 en


Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics